SARA
HERNANDO REVILLA
Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina
Madrid, EspañaCentro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina -ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2023
-
Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 5
2022
-
Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures
Fluids and Barriers of the CNS, Vol. 19, Núm. 1
2020
-
Nanostructured lipid carriers made of Ω-3 polyunsaturated fatty acids: In vitro evaluation of emerging nanocarriers to treat neurodegenerative diseases
Pharmaceutics, Vol. 12, Núm. 10, pp. 1-22
2019
-
Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation
Neurobiology of Disease, Vol. 121, pp. 252-262
2018
-
Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson’s disease
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 145-155
-
The role of lipid nanoparticles and its surface modification in reaching the brain: An approach for neurodegenerative diseases treatment
Current Drug Delivery, Vol. 15, Núm. 9, pp. 1218-1220
2017
-
Nanotechnology based approaches for neurodegenerative disorders: Diagnosis and treatment
Drug and Gene Delivery to the Central Nervous System for Neuroprotection: Nanotechnological Advances (Springer International Publishing), pp. 57-87
2016
-
Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases
Nanomedicine, Vol. 11, Núm. 10, pp. 1267-1285